⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SILO News
Silo Pharma, Inc. Common Stock
Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program
globenewswire.com
SILO
Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request
globenewswire.com
SILO
Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial
globenewswire.com
SILO
Form 8-K
sec.gov
SILO
Silo Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
globenewswire.com
SILO
Form 8-K
sec.gov
SILO
Form 8-K
sec.gov
SILO
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
globenewswire.com
SILO
Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
globenewswire.com
SILO
Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents
globenewswire.com
SILO